Articles related to RETINA

According to Elizabeth Cifers, MBA, a practice management consultant specializing in retina practice: “The key is to focus on medical necessity for the information the test will provide, rather than ordering an OCTA routinely.”

“This acquisition immediately advances Biogen’s ongoing transformation… with two approved, best-in-class medicines that complement our existing portfolio.”
— Christopher Viehbacher, President and CEO, Biogen

“These findings support the role of OCTA as an adjunctive tool for monitoring [hydroxychloroquine-induced] retinal changes, while further longitudinal studies are needed to clarify its predictive value.” – Study authors

The specialty treats a diverse patient population and the scientific discourse should reflect that breadth of experience and insight. Breaking these patterns requires intentional effort and sustained commitment.

“Axpaxli is the first and only investigational product in wet AMD with a novel mechanism of action to successfully demonstrate superiority to an approved anti-VEGF agent since their initial approval more than 20 years ago.” — Pravin U. Dugel, MD, Ocular Therapeutix

Although surgical retina procedures may use similar techniques, the CPT code that accurately reflects the surgery performed is often best identified by the diagnosis that led to the surgery.